Annual EBITDA
-$12.02 M
+$4.37 M+26.66%
01 December 2023
Summary:
NLS Pharmaceutics AG annual earnings before interest, taxes, depreciation & amortization is currently -$12.02 million, with the most recent change of +$4.37 million (+26.66%) on 01 December 2023. During the last 3 years, it has fallen by -$9.39 million (-357.26%). NLSP annual EBITDA is now -357.26% below its all-time high of -$2.63 million, reached on 31 December 2020.NLSP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLSP EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.7% | - | - |
| 3 y3 years | -357.3% | - | - |
| 5 y5 years | -195.8% | - | - |
NLSP EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -357.3% | +26.7% | ||||
| 5 y | 5 years | -357.3% | +26.7% | ||||
| alltime | all time | -357.3% | +26.7% |
NLS Pharmaceutics AG EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$12.02 M(-26.7%) | - | - |
| Dec 2022 | -$16.38 M(+38.0%) | - | - |
| Dec 2021 | -$11.87 M(+351.6%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$2.63 M(-43.2%) | - | - |
| Dec 2019 | -$4.63 M(+13.9%) | - | - |
| Dec 2018 | -$4.06 M(-29.6%) | - | - |
| Dec 2017 | -$5.77 M | - | - |
FAQ
- What is NLS Pharmaceutics AG annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual EBITDA year-on-year change?
What is NLS Pharmaceutics AG annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NLSP is -$12.02 M
What is the all time high annual EBITDA for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual earnings before interest, taxes, depreciation & amortization is -$2.63 M
What is NLS Pharmaceutics AG annual EBITDA year-on-year change?
Over the past year, NLSP annual earnings before interest, taxes, depreciation & amortization has changed by +$4.37 M (+26.66%)